Corvasce Antonio, Albino Giuseppe, Leonetti Teresa, Buonomo Agnese Filomena, Marucco Ettore Cirillo
Unit of Urology, "L. Bonomo" Hospital, ASL BAT, Andria; Centre of Andrology and Reproductive Pro.Andròs certified ISO 9001-2008 certified SIA.
Arch Ital Urol Androl. 2015 Sep 30;87(3):210-3. doi: 10.4081/aiua.2015.3.210.
We explored the safety of Tadalafil once-daily treatment for 12 week and its effects on semen quality in a clinical subpopulation of men with psychogenic erectile dysfunction (ED).
Twenty-seven men, between 19 and 35 years, unaware of their fertility status, suffering from psychogenic ED were enrolled. The examination of the seminal fluid was performed twice before administration of Tadalafil and twice after three months of continuous daily administration of Tadalafil 5 mg. The volume of the seminal fluid, the concentration of sperm, the concentration of sperm with type "a+b" motility, the concentration of sperm with type "a" motility, the concentration of normal sperm were taken into consideration. The results before treatment with Tadalafil (T0) and after 3 months of treatment (T3m) were compared.
The administration of once-daily Tadalafil 5mg, brings to an average increase of the total number of sperm cells, both total and fast motility (type a) and the percentage of nemasperms, and to an average increase of semen volume of only 0.41 ml. These quantitative and qualitative improvements of the seminal fluid resulted statistically significant as regard motility, nemasperm percentage and seminal fluid volume. No unespected safety findings were observed.
Tadalafil administration improves the quality of sperm cells and seminal fluid: in particular motility, percentage of nemasperms and volume of seminal fluid. We emphasize the safety of the once-daily treatment with tadalafil 5mg and the positive effects on spermatogenesis.
我们探讨了他达拉非每日一次治疗12周对心因性勃起功能障碍(ED)男性临床亚组的安全性及其对精液质量的影响。
纳入27名年龄在19至35岁之间、未意识到自己生育状况且患有心因性ED的男性。在服用他达拉非之前和连续每日服用5毫克他达拉非三个月后分别进行两次精液检查。考虑精液体积、精子浓度、“a + b”级运动精子浓度、“a”级运动精子浓度、正常精子浓度。比较他达拉非治疗前(T0)和治疗3个月后(T3m)的结果。
每日一次服用5毫克他达拉非,使精子细胞总数、总运动性和快速运动性(a级)以及正常精子百分比平均增加,精液体积仅平均增加0.41毫升。精液在运动性、正常精子百分比和精液体积方面的这些定量和定性改善在统计学上具有显著意义。未观察到意外的安全性发现。
服用他达拉非可改善精子细胞和精液质量:特别是运动性、正常精子百分比和精液体积。我们强调每日一次服用5毫克他达拉非治疗的安全性及其对精子发生的积极作用。